Day 100 Risk Assessment Tool Predicts 1 Year Survival in Allogeneic Hematopoietic Cell Transplant Patients

被引:0
|
作者
Farinella, Joseph [1 ]
Granat, Lauren M. [2 ]
Li, Hong [3 ]
Caroniti, Sharon M. [1 ]
Hegde, Pranay S. [4 ]
Kalaycio, Matt [5 ]
Sobecks, Ronald [6 ]
Brunstein, Claudio [5 ]
Sauter, Craig S. [5 ]
Hamilton, Betty K. [7 ]
机构
[1] Cleveland Clin, Blood & Marrow Transplant, Cleveland, OH 44106 USA
[2] Cleveland Clin, Internal Med, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Biostat & Quantitat Hlth Sci, Cleveland, OH 44106 USA
[4] NHLBI, Lab Myeloid Malignancies, Hematol Branch, Cleveland, OH USA
[5] Cleveland Clin, Dept Hematol & Med Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA
[6] Cleveland Clin, Blood & Marrow Transplant Taussig Canc Inst, Cleveland, OH 44106 USA
[7] Cleveland Clin Fdn, Taussig Canc Inst, Dept Hematol & Med Oncol, 9500 Euclid Ave, Cleveland, OH 44195 USA
关键词
D O I
10.1182/blood-2023-189629
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Monocyte Recovery at Day 100 Is Associated with Improved Survival in Multiple Myeloma Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation
    Dhakal, Binod
    Brazauskas, Ruta
    Arce-lara, Carlos
    Hari, Parameswaran N.
    Pasquini, Marcelo C.
    D'Souza, Anita
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S163 - S164
  • [22] Interventions in allogeneic transplantation patients after day 100 till 1 year
    Pol, R. R.
    Russell, N.
    Das-Gupta, E.
    Watson, L.
    Rachael, L.
    Byrne, J.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S427 - S427
  • [23] A Primed Neutrophil Subset Predicts the Risk of Bloodstream Infections in Allogeneic Hematopoietic Stem-Cell Transplant Patients: A Prospective Study
    Elebyary, Omnia
    Fine, Noah
    Sun, Chunxiang
    Saha, Sourav T.
    Robinson, Shawn
    Mojdami, Zahra Dorna
    Khoury, Nicole
    Watson, Erin
    Coburn, Bryan
    Lipton, Jeffrey H.
    Glogauer, Michael
    CLINICAL INFECTIOUS DISEASES, 2023, : 752 - 760
  • [24] Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant
    Syrjala, KL
    Dikmen, S
    Langer, SL
    Roth-Roemer, S
    Abrams, JR
    BLOOD, 2004, 104 (10) : 3386 - 3392
  • [25] Pilot Study - Composite Risk Score for Pre-Transplant Risk Assessment in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
    Kaur, Jaskiran
    Altman, Rebekah
    Muthukutty, Anusha
    Ragupathi, Madhu
    Pineiro, Luis
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [26] ABSOLUTE LYMPHOCYTE COUNT AT DAY 30 PREDICTS SURVIVAL IN RECIPIENTS OF A T CELL DEPLETED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Goldberg, J. D.
    Lai, K. C.
    Jokubowski, A. A.
    Barker, J. N.
    Boulad, F.
    Castro-Malaspina, H. R.
    Hsu, K. C.
    Kernan, N.
    O'Reilly, R. J.
    Papadopoulos, E. B.
    Prockop, S.
    Scaradavou, A.
    Small, T. N.
    van den Brink, M. R. M.
    Young, J. W.
    Heller, G.
    Perales, M. -A
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 141 - 142
  • [27] A Comprehensive Model for Predicting 1-Year Survival after Allogeneic Hematopoietic Cell Transplantation in Older Patients
    Gera, Kriti
    Mathavan, Akash
    Mathavan, Akshay
    Tillotson, Sophie G.
    Liu, Xingke
    Guo, Yi
    Farhadfar, Nosha
    Hsu, Jack W.
    Hiemenz, John W.
    Wingard, John R.
    Al-Mansour, Zeina A.
    BLOOD, 2023, 142
  • [28] Estimating Long-Term Survival in a Cohort of Allogeneic Hematopoietic Stem Cell Transplant Patients
    Palmer, Stephen
    Quinn, Casey
    Watson, Crystal
    Barlev, Arie
    BLOOD, 2018, 132
  • [29] The Glasgow Prognostic Score as a pre-transplant risk assessment for allogeneic hematopoietic cell transplantation
    Shibasaki, Yasuhiko
    Suwabe, Tatsuya
    Katagiri, Takayuki
    Tanaka, Tomoyuki
    Kobayashi, Hironori
    Fuse, Kyoko
    Ushiki, Takashi
    Sato, Naoko
    Yano, Toshio
    Kuroha, Takashi
    Hashimoto, Shigeo
    Narita, Miwako
    Furukawa, Tatsuo
    Sone, Hirohito
    Masuko, Masayoshi
    CLINICAL TRANSPLANTATION, 2017, 31 (11)
  • [30] Evaluation of pre-transplant risk assessments in allogeneic hematopoietic cell transplant
    Pranay S. Hegde
    Lisa Rybicki
    Sheila Serafino
    Laura Bernhard
    Donna Corrigan
    Faiz Anwer
    Matt Kalaycio
    Ronald M. Sobecks
    Deepa Jagadeesh
    Brian T. Hill
    Robert M. Dean
    Jack Khouri
    Allison M. Winter
    Brad Pohlman
    Navneet S. Majhail
    Betty K. Hamilton
    Bone Marrow Transplantation, 2022, 57 : 1031 - 1033